DigmBio logo

DigmBio

Website
Current Valuation
N/A
As of March 25, 2025
Total Funding Raised
$10.6M
Last Round
Early Stage VC

$8.3M

Last Funding
Mar 2025

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

DigmBio is currently valued at N/A as of March 25, 2025. The company has raised a total of $10.6M in funding.

Investment Perspective

DigmBio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track DigmBio Valuation Updates

Get notified when DigmBio raises new funding or valuation changes

Explore More Data
Detailed analysis for DigmBio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

What is DigmBio Worth in 2025?

As of 2025, DigmBio is valued at N/A, based on the company's Early Stage VC funding round in March 25, 2025. This valuation positions DigmBio as one of the leading private companies in the sector.

DigmBio Valuation History

DigmBio's funding history demonstrates steady growth and investor confidence.

How DigmBio Valuation is Determined

Private company valuations like DigmBio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

DigmBio Valuation FAQs

Is DigmBio profitable?

DigmBio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does DigmBio's valuation compare to competitors?

DigmBio is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will DigmBio IPO?

DigmBio has not announced plans for an initial public offering. Until an IPO, investors can access DigmBio shares through secondary market platforms.